TORCHIO, SILVIA
TORCHIO, SILVIA
Facoltà di Medicina e Chirurgia
A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome
2024-01-01 Chimienti, R.; Torchio, S.; Siracusano, G.; Zamarian, V.; Monaco, L.; Lombardo, M. T.; Pellegrini, S.; Manenti, F.; Cuozzo, F.; Rossi, G.; Carrera, P.; Sordi, V.; Broccoli, V.; Bonfanti, R.; Casari, G.; Frontino, G.; Piemonti, L.
Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients
2021-01-01 Frontino, G.; Raouf, T.; Canarutto, D.; Tirelli, E.; Di Tonno, R.; Rigamonti, A.; Cascavilla, M. L.; Baldoli, C.; Scotti, R.; Leocani, L.; Huang, S. -C.; Meschi, F.; Barera, G.; Broccoli, V.; Rossi, G.; Torchio, S.; Chimienti, R.; Bonfanti, R.; Piemonti, L.
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement
2022-01-01 Chimienti, Raniero; Baccega, Tania; Torchio, Silvia; Manenti, Fabio; Pellegrini, Silvia; Cospito, Alessandro; Amabile, Angelo; Lombardo, Marta Tiffany; Monti, Paolo; Sordi, Valeria; Lombardo, Angelo; Malnati, Mauro; Piemonti, Lorenzo
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes
2019-01-01 Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Pritchard-Meaker, T; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes
2020-01-01 Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Cospito, A; Monti, P; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L
In vitro iPSC modelling of a Wolfram syndrome patient suggests relationship between ER dysfunctions and disease pathogenesis
2019-01-01 Torchio, S; Chimienti, R; Manenti, F; Rossi, G; Cancellieri, C; Pellegrini, S; Sordi, V; Broccoli, V; Frontino, G; Meschi, F; Piemonti, L
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy
2021-01-01 Careccia, G.; Saclier, M.; Tirone, M.; Ruggieri, E.; Principi, E.; Raffaghello, L.; Torchio, S.; Recchia, D.; Canepari, M.; Gorzanelli, A.; Ferrara, M.; Castellani, P.; Rubartelli, A.; Rovere-Querini, P.; Casalgrandi, M.; Preti, A.; Lorenzetti, I.; Bruno, C.; Bottinelli, R.; Brunelli, S.; Previtali, S. C.; Bianchi, M. E.; Messina, G.; Venereau, E.
WOLFRAM SYNDROME: FROM POINT MUTATION TO CELL DYSFUNCTION
2022-05-12 Torchio, Silvia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome | 1-gen-2024 | Chimienti, R.; Torchio, S.; Siracusano, G.; Zamarian, V.; Monaco, L.; Lombardo, M. T.; Pellegrini, S.; Manenti, F.; Cuozzo, F.; Rossi, G.; Carrera, P.; Sordi, V.; Broccoli, V.; Bonfanti, R.; Casari, G.; Frontino, G.; Piemonti, L. | |
| Case Report: Off-Label Liraglutide Use in Children With Wolfram Syndrome Type 1: Extensive Characterization of Four Patients | 1-gen-2021 | Frontino, G.; Raouf, T.; Canarutto, D.; Tirelli, E.; Di Tonno, R.; Rigamonti, A.; Cascavilla, M. L.; Baldoli, C.; Scotti, R.; Leocani, L.; Huang, S. -C.; Meschi, F.; Barera, G.; Broccoli, V.; Rossi, G.; Torchio, S.; Chimienti, R.; Bonfanti, R.; Piemonti, L. | |
| Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement | 1-gen-2022 | Chimienti, Raniero; Baccega, Tania; Torchio, Silvia; Manenti, Fabio; Pellegrini, Silvia; Cospito, Alessandro; Amabile, Angelo; Lombardo, Marta Tiffany; Monti, Paolo; Sordi, Valeria; Lombardo, Angelo; Malnati, Mauro; Piemonti, Lorenzo | |
| Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes | 1-gen-2019 | Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Pritchard-Meaker, T; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L | |
| Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes | 1-gen-2020 | Chimienti, R; Baccega, T; Manenti, F; Torchio, S; Pellegrini, S; Cospito, A; Monti, P; Sordi, V; Lombardo, A; Malnati, M; Piemonti, L | |
| In vitro iPSC modelling of a Wolfram syndrome patient suggests relationship between ER dysfunctions and disease pathogenesis | 1-gen-2019 | Torchio, S; Chimienti, R; Manenti, F; Rossi, G; Cancellieri, C; Pellegrini, S; Sordi, V; Broccoli, V; Frontino, G; Meschi, F; Piemonti, L | |
| Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy | 1-gen-2021 | Careccia, G.; Saclier, M.; Tirone, M.; Ruggieri, E.; Principi, E.; Raffaghello, L.; Torchio, S.; Recchia, D.; Canepari, M.; Gorzanelli, A.; Ferrara, M.; Castellani, P.; Rubartelli, A.; Rovere-Querini, P.; Casalgrandi, M.; Preti, A.; Lorenzetti, I.; Bruno, C.; Bottinelli, R.; Brunelli, S.; Previtali, S. C.; Bianchi, M. E.; Messina, G.; Venereau, E. | |
| WOLFRAM SYNDROME: FROM POINT MUTATION TO CELL DYSFUNCTION | 12-mag-2022 | Torchio, Silvia |